Liposomal amphotericin B followed by voriconazole for secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients

被引：0
|
作者：
Allinson, K.
Kolve, H.
Gumbinger, H. G.
Vormoor, H. J.
Ehlert, K.
Groll, A. H.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70816-6
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [41] Galactomannan antigen in children undergoing allogeneic stem cell transplantation and antifungal prophylaxis with voriconazole
    Buenasmananas, D.
    Molina, J. R.
    Rodriguez-Villa, A.
    Martinez-Losada, C.
    Garcia-Torres, E.
    Gomez-Garcia, L. M.
    Rojas, R.
    Martin, C.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S291 - S292
  • [42] Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
    Bruggemann, Roger J. M.
    Blijlevens, N. M. A.
    Burger, David M.
    Franke, Barbara
    Troke, Peter F.
    Donnelly, J. Peter
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (01) : 107 - 113
  • [43] SAFETY AND EFFICACY OF LOW DOSE LIPOSOMAL AMPHOTERICIN B (L-AMB) FOLLOWED BY MICAFUNGIN PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS (IFI) IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) RECIPIENTS
    Elmacken, Mona
    Ours, Christopher
    Mitchell, Daniel
    Militano, Olga
    Vandeven, Carmella
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S104 - S104
  • [44] Safety of a weekly administration of 10 mg/kg of liposomal amphotericin B for antifungal prophylaxis in allogeneic stem-cell transplant and acute leukemia patients.
    Cordonnier, C
    Mohty, M
    Faucher, C
    Vey, N
    Pautas, C
    Robin, M
    Mahi, L
    Ribaud, P
    BLOOD, 2005, 106 (11) : 422B - 422B
  • [45] Predictors for invasive fungal infection in paediatric allogeneic haematopoietic stem cell transplantation recipients
    Hol, J. A.
    Wolfs, T. F. W.
    Bierings, M. B.
    Lindemans, C. A.
    Versluys, A. B. J.
    De Wildt, A.
    Gerhardt, C. E.
    Boelens, J. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S318 - S318
  • [46] Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant
    Deambrosis, David
    Davies, Emma
    Turner, Andrew
    Guiver, Malcolm
    Bonney, Denise
    Campbell, Helen
    Wynn, Robert F.
    Hiwarkar, Prashant
    JOURNAL OF CLINICAL VIROLOGY, 2020, 127
  • [47] VORICONAZOLE AS ANTIFUNGAL PROPHYLAXIS DURING NEUTROPENIC PHASE IN CHILDREN UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Molina, J. R.
    Buenasmananas, D.
    Garcia-Torres, E.
    Rodriguez-Villa, A.
    Rojas, R.
    Martin, C.
    Serrano, J.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S375 - S376
  • [48] Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis
    Nihtinen, A.
    Anttila, V. -J.
    Ruutu, T.
    Juvonen, E.
    Volin, L.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (01) : 24 - 32
  • [49] Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
    Bogler, Yael
    Stern, Anat
    Su, Yiqi
    Lee, Yeon Joo
    Seo, Susan K.
    Shaffer, Brian
    Perales, Miguel-Angel
    Papanicolaou, Genovefa A.
    Neofytos, Dionysios
    MEDICAL MYCOLOGY, 2021, 59 (10) : 970 - 979
  • [50] Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients
    Falagas, ME
    Vardakas, KZ
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (04) : 299 - 300
12345